How Does Influenza A (H1N1) Infection Proceed in Allogeneic Stem Cell Transplantation Recipients?
TURKISH JOURNAL OF HEMATOLOGY, cilt.29, sa.1, ss.63-66, 2012 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 1
- Basım Tarihi: 2012
- Doi Numarası: 10.5152/tjh.2011.74
- Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.63-66
- Anahtar Kelimeler: H1N1, Allogeneic transplantation, VACCINE, VIRUS
- Ankara Üniversitesi Adresli: Evet
Özet
The clinical course of influenza A (H1N1) infection in allogeneic hematopoietic stem cell transplantation (AHSCT) recipients is not clearly known. We report 3 AHSCT recipients that were infected with influenza A (H1N1). Each of the patients had a different hematological disease and was at a different post-transplantation stages. All the patients were treated with oseltamivir, and zanamivir was switched to oseltamivir in 1 patient. All the patients survived without any complications. The course of swine flu can vary and progress with bacterial or other viral infections in immunosuppressed patients.